Novo Nordisk shares plunge 15% after Wegovy-maker cuts full-year guidance
-
最新报道：Novo Nordisk shares dropped sharply after the Wegovy maker lowered its full-year sales and operating profit guidance, citing supply constraints and manufacturing challenges. The Danish pharmaceutical giant now expects sales growth of 19-21% and operating profit growth of 21-24%, down from previous forecasts of 24-27% and 28-31% respectively. The company continues to face high demand for its obesity and diabetes drugs but struggles to ramp up production capacity. Novo Nordisk CEO Lars Fruergaard Jørgensen stated they're investing heavily in manufacturing expansion but warned supply issues may persist into 2026. The guidance cut comes despite strong Q2 results showing 30% sales growth to $7.8 billion.
下一篇
Stellantis Faces €1.2B Tariff Hit, 25% North America Shipments Drop as Shares Fall 4.1% on Revised Margins
- Stellantis warns of potential €1.2 billion in EU tariffs on its China-made vehicles if pro...
24小时热点
热点专题
413124